Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ruyan Huadu Tang is a Traditional Chinese Medicine (TCM) herbal decoction primarily used in the treatment of breast cancer, which is referred to as 'Ruyan' in TCM literature. The formula is designed to clear heat, resolve toxins, dissipate phlegm, and soften hardness, addressing the 'toxic heat' and 'phlegm-stagnation' patterns often associated with malignant tumors. It typically comprises a complex mixture of herbs including *Hedyotis diffusa*, *Scutellaria barbata*, *Taraxacum*, and *Lonicera japonica*. In clinical settings, particularly in China, it is frequently employed as an adjuvant therapy alongside conventional treatments like chemotherapy, radiotherapy, or surgery to enhance therapeutic efficacy, mitigate adverse effects, and improve the overall survival and quality of life for breast cancer patients.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ruyan Huadu Tang.